| |
| |
|
| Insider
Information: |
Mattessich Antony C. |
| Relationship: |
President and CEO, Dir... |
| City: |
Bedford |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
588,701 |
|
|
Indirect Shares
|
6,500 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
595,201 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ocular Therapeutix, Inc |
OCUL |
President and CEO, Dir... |
2024-02-05 |
588,701 |
2024-02-05 |
6,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2024-02-05 |
4 |
S |
$4.86 |
$95,460 |
D/D |
(19,642) |
588,701 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2024-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
180,400 |
608,343 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2024-01-31 |
4 |
S |
$4.95 |
$90,773 |
D/D |
(18,338) |
427,943 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2023-08-30 |
4 |
B |
$3.81 |
$24,765 |
I/I |
6,500 |
6,500 |
2.58 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2023-02-06 |
4 |
AS |
$4.24 |
$83,397 |
D/D |
(19,669) |
446,281 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
176,300 |
465,950 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• – – |
2022-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
186,750 |
289,650 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2021-08-20 |
4 |
B |
$9.89 |
$49,450 |
D/D |
5,000 |
102,900 |
2.81 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President & CEO |
• • – |
2019-06-06 |
4 |
B |
$2.81 |
$112,400 |
D/D |
40,000 |
97,900 |
2.81 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President & CEO |
• • – |
2018-08-20 |
4 |
B |
$5.95 |
$119,000 |
D/D |
20,000 |
57,900 |
2.81 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and CEO |
• • – |
2018-08-10 |
4 |
B |
$6.23 |
$105,287 |
D/D |
16,900 |
37,900 |
2.81 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
President and C.E.O. |
• • – |
2017-12-12 |
4 |
B |
$4.29 |
$90,090 |
D/D |
21,000 |
21,000 |
2.81 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
